fda semaglutide news The approved a pill version of the GLP-1 receptor agonist (Wegovy), making it the first oral GLP-1 agent indicated for weight loss, Novo Nordisk announced on Monday. The once-daily 25 FDA moves to stop compounding

Intraretinal microvascular abnormalities in eyes with advanced stages of nonproliferative diabetic retinopathy: comparison between UWF-FFA, CFP, and OCTA-The RICHARD Study

Vitamin C intake and the risk of gout in men: a prospective study

There are a number of recent studies on neurexins and the transsynaptic complexes formed by neurexins that relate to synaptic plasticity

Guidance on this front is important since research has uncovered that BPC-157 may have important research applications like: Improving injury recovery Stimulating wound healing Reducing gut inflammation Below, we detail what researchers must know about experimenting with this peptide, along with presenting a BPC-157 dosage calculator, safety protocols, and potential side effects